ExodusPoint Capital Management, LP

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1736225 NEW YORK, NY

Back to TERN Full portfolio

Position in TERN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

+$0 QoQ

Shares Held

80,245

-78.6% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

153,400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

All Filings in TERN

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	153,400	—	Call	Sole	2026-05-14
2026-03-31	—	80,245	-78.6%	Shares	Sole	2026-05-14
2025-12-31	—	375,673	+3373.3%	Shares	Sole	2026-02-17
2024-12-31	—	10,816	-99.3%	Shares	Sole	2025-02-12
2024-09-30	—	1,648,131	+2911.8%	Shares	Sole	2024-11-12
2024-03-31	—	54,722	+15.1%	Shares	Sole	2024-05-14
2023-12-31	—	47,540	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.